Persistent URL of this record https://hdl.handle.net/1887/98323
In Collections
This item can be found in the following collections:
Oskira-3: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To a Tumor Necrosis Factor-alpha Antagonist
- All authors
- Genovese, M.; Heijde, D. van der; Keystone, E.; Spindler, A.; Benhamou, C.L.; Kavanaugh, A.; Fudman, E.; Lampl, K.; O'Brien, C.; Duffield, E.; Poiley, J.; Weinblatt, M.
- Date
- 2013-10-31
- Journal
- Arthritis and Rheumatism
- Volume
- 65
- Pages
- S199 - S200